Sign in

CIK 0001728328

  • Emerging growth company

Mentari Therapeutics, Inc.

Sign in to watch
Ticker
MTRI
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
NV
Entity type
Operating
EIN
981428279
Phone
+1 781-887-5080
Business address
221 CRESCENT STREET, BUILDING 23, SUITE 105, WALTHAM, MA, 02453
Former names
InMed Pharmaceuticals Inc.
Open-market buys, last 90 days
$238,371
in 7 filings
Open-market sales, last 90 days
$0
in 0 filings

Net +$238,371. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. ADAR1 Capital Management, LLC +$238K 10% owner 7 filings
Date Insider Transaction Shares Price Value Owned after
2025-12-19 Johnson Shane Aaron Sr VP & General Manager Grant or award · Employee Stock Option (Right to Buy) +8,500 12,400
2024-12-20 Johnson Shane Aaron Sr VP & General Manager Grant or award · Employee Stock Option (Right to Buy) +1,500 3,900
2023-12-23 Johnson Shane Aaron Sr VP & General Manager Grant or award · Employee Stock Option (Right to Buy) +40,000 48,000
2022-12-16 Johnson Shane Aaron Sr VP & General Manager Grant or award · Employee Stock Option (Right to Buy) +4,200 8,000
2022-11-14 Johnson Shane Aaron Sr VP & General Manager Returned to the company · Employee Stock Option (Right to Buy) −4,200 3,800
2022-11-14 Johnson Shane Aaron Sr. VP & General Manager Grant or award · Employee Stock Option (Right to Buy) +4,200 8,000
2022-01-06 Johnson Shane Aaron SVP, GM of BayMedica LLC Purchase +8,500 $1.26 $11K 304,595
2021-12-30 Johnson Shane Aaron SVP, GM of BayMedica LLC Purchase +8,093 $1.33 $11K 296,095
2021-11-15 Johnson Shane Aaron SVP, GM of BayMedica LLC Purchase +5,000 $1.37 $7K 288,002

Page 1 of 1 · 9 trades